2021
DOI: 10.1016/j.bioorg.2021.104813
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 64 publications
0
2
0
Order By: Relevance
“…However, there are no table entries for papers targeting proteases, the first time this target class has not been represented. In contrast, there are more examples of GPCR case studies in Table than in previous years (entries 26, 27, and 28), including the description of the discovery of the M1 agonist clinical compound HTL9936 (entry 28). …”
Section: Resultsmentioning
confidence: 99%
“…However, there are no table entries for papers targeting proteases, the first time this target class has not been represented. In contrast, there are more examples of GPCR case studies in Table than in previous years (entries 26, 27, and 28), including the description of the discovery of the M1 agonist clinical compound HTL9936 (entry 28). …”
Section: Resultsmentioning
confidence: 99%
“…High-throughput screening applying Lipinsky’s “rules of five” in structure–activity relationship studies combined with computational analyses and robotics is a frequently used methodology to identify the most promising compounds during drug discovery of low-molecular-weight targets in a fairly short period of time. The method also allows identification of specific positions in the low-molecular-weight targets for modifications to achieve desired properties, such as water or fat solubility, altered binding affinity by the modified strength of H-bonds, and others.…”
Section: Introductionmentioning
confidence: 99%